Novo Nordisk (NVO) backed MapLight Therapeutics will raise $258.9M in an IPO and private placement, Avalon Pernell of Bloomberg reports. The company sold 14.75M shares for $17 each.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Mixed options sentiment in Novo Nordisk with shares down 0.59%
- Novo Nordisk Shares (NVO) Slip after Largest Shareholder Proposes Major Board Shake-Up
- Midday Fly By: Netflix, TI reports weigh on markets
- Mixed options sentiment in Novo Nordisk with shares down 2.58%
- Trump Trade: Trump administration prepares new probe into pharma prices